• Exchange: Continuous
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

GRF:SM

38.9450 EUR 0.2650 0.68%

As of 05:49:07 ET on 07/30/2014.

Snapshot for Grifols SA (GRF)

Open: 39.3250 Day's Range: 38.7800 - 39.3500 Volume: 106,228
Previous Close: 39.2100 52wk Range: 28.2500 - 42.5300 1-Yr Rtn: +23.96%

Stock Chart for GRF

No chart data available.
  • GRF:SM 38.9200
  • 1D
  • 1M
  • 1Y
39.2100
Interactive GRF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for GRF

Current P/E Ratio (ttm) 35.9943
Estimated P/E(12/2014) 21.4028
Relative P/E vs. IBEX 1.5230
Earnings Per Share (EUR) (ttm) 1.0893
Est. EPS (EUR) (12/2014) 1.8320
Est. PEG Ratio 1.1477
Market Cap (M EUR) 12,488.71
Shares Outstanding (M) 213.06
30 Day Average Volume 720,394
Price/Book (mrq) 4.1964
Price/Sale (ttm) 4.6479
Dividend Indicated Gross Yield 0.51%
Cash Dividend (EUR) 0.1585
Dividend Ex-Date 06/05/2014
5 Year Dividend Growth -1.58%
Next Earnings Announcement 07/31/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for GRF

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for GRF

Grifols S.A. develops, manufactures, and markets plasma derivatives, IV Therapy, Enteral nutrition, diagnostic systems, and medical materials.

Victor Grifols RouraChairman/CEORamon Riera RocaExec VP/Pres:Global Commercial
Alfredo Arroyo GuerraVP/CFOCarlos Roura FernandezVP/Pres:Global Industrial
More Company Profile & Key Executives for GRF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil